America’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots ...
Bayer's Monsanto has sued Pfizer, BioNTech and Moderna for allegedly misusing its messenger RNA technology in COVID-19 vaccines. The patent infringement lawsuits say the companies have copied ...
The vaccine maker’s shots involve the successful Covid vaccines’ RNA technology. Health Secretary Robert F. Kennedy Jr. has ...
The Food and Drug Administration rejected Moderna's new flu shot. This raises questions about what it means for the future of vaccine development.
The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu ...
The Food and Drug Administration rejected Moderna’s application for its mRNA-based flu vaccine, the drugmaker said Tuesday ...
この資料は、米国ファイザー社が2023年6月30日（米国現地時間）に発表したプレスリリースの一部を日本語に翻訳再編集し、皆さまのご参考に供するものです。正式言語は英語であり、その内容及び解釈については英語が優先されます。 https://www.pfizer.com ...
According to Bayer’s lawsuits, Monsanto scientists pioneered technology in the 1980s to stabilise mRNA for pest-resistant crops. (Reuters pic) Bayer’s Monsanto sued Covid-19 vaccine makers Pfizer, ...
The FDA’s refusal to review Moderna’s mRNA-based flu vaccine is “part of a disturbing pattern” of moving regulatory goalposts, according to Clay Alspach, executive director of the Alliance for mRNA ...
[12日 ロイター] - 米製薬大手・ファイザー(PFE.N), opens new tabは12日、同社のメッセンジャーRNA（mRNA）ワクチン・ポートフォリオからの年間売上高が2030年までに100億─150億ドルに達する可能性があると明らかにした。 新型コロナ ...
Moderna said it’s requesting a meeting with the U.S. Food and Drug Administration after receiving a “refusal-to-file” letter, which means the FDA isn’t going to review the company’s advanced-stage ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する